2025年1月24日，生命科学工具和服务公司赛默飞世尔（TMO）成交额为6.65亿美元，在当日美股中排第127名，成交额较昨日减少6.61%，当日成交量为115.65万。 赛默飞世尔（TMO）于2025年1月24日跌0.01%，报574.82美元，该股过去5个交易日涨2.71%，整个1月涨10.49%，年初至今涨10.49%，过去52周涨6.80%。 *如果公司上市时间少于52周，则52周涨跌幅为 ...

Thermo Fisher Scientific Inc.’s TMO recent slew of product launches reflects its ongoing commitment to innovation. The company gains early insights into customer needs through its strong partnerships, ...

A bioscience business that develops and makes medications for pharmaceutical companies and started in Bend nine years ago is ...

Often dismissed as the poor cousin of the sciences, chemistry has revealed natural laws that illuminate our Universe ...

NKY economic development leaders are bullish on 2025 given a strong deal pipeline and the prospect of capturing foreign ...

Iconic San Francisco institution receives national recognition from USA Today–public voting open through February 10 ...

The healthcare industry is in a transformative period. At the center of this change are the medical device companies of Northern Kentucky.

Now in its 84th year, the competition identifies extraordinary young minds who blend scientific talent, curiosity and bold leadership to drive meaningful change for society. Regeneron Science Talent ...

Brett Girard, chief financial officer and portfolio manager at Liberty International Investment Management, discusses his top ...

The market expects Thermo Fisher Scientific (TMO) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known ...

Intuitive is buying businesses that distribute its da Vinci and Ion surgical robots to establish a direct presence in Italy, ...

Roche plans to release the system in the US to run tests including vitamin D and steroid assays under CLIA before it possibly receives US Food and Drug Administration clearance.